INFLIXIMAB-ABDA for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 16 adverse event reports in the FDA FAERS database where INFLIXIMAB-ABDA was used for Psoriasis.
Most Reported Side Effects for INFLIXIMAB-ABDA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 493 | 27.2% | 6 | 178 |
| Product use issue | 272 | 15.0% | 3 | 86 |
| Dyspnoea | 145 | 8.0% | 0 | 44 |
| Nausea | 142 | 7.9% | 1 | 34 |
| Crohn's disease | 133 | 7.4% | 0 | 54 |
| Arthralgia | 131 | 7.2% | 2 | 56 |
| Diarrhoea | 118 | 6.5% | 4 | 49 |
| Drug ineffective | 111 | 6.1% | 1 | 44 |
| Headache | 111 | 6.1% | 2 | 32 |
| Malaise | 111 | 6.1% | 3 | 50 |
| Abdominal pain | 107 | 5.9% | 0 | 36 |
| Fatigue | 107 | 5.9% | 3 | 32 |
| Pruritus | 107 | 5.9% | 0 | 35 |
| Vomiting | 102 | 5.6% | 1 | 35 |
| Rash | 101 | 5.6% | 1 | 37 |
Other Indications for INFLIXIMAB-ABDA
Crohn's disease (703)
Colitis ulcerative (371)
Product used for unknown indication (246)
Rheumatoid arthritis (144)
Ankylosing spondylitis (87)
Psoriatic arthropathy (61)
Hidradenitis (35)
Sarcoidosis (28)
Colitis (22)
Behcet's syndrome (17)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)